
Sign up to save your podcasts
Or


Summarize the paper by Asselin et al and review the risks of therapy-related cardiomyopathy and evidence supporting dexrazoxane use in pediatric oncology.
By American Society of Clinical Oncology (ASCO)3.8
3939 ratings
Summarize the paper by Asselin et al and review the risks of therapy-related cardiomyopathy and evidence supporting dexrazoxane use in pediatric oncology.

14,359 Listeners

139 Listeners

319 Listeners

498 Listeners

58 Listeners

112,751 Listeners

44 Listeners

32 Listeners

195 Listeners

91 Listeners

363 Listeners

253 Listeners

189 Listeners

41 Listeners

613 Listeners